4//SEC Filing
Avnur Zafrira 4
Accession 0001209191-18-038717
CIK 0001035354other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 9:31 PM ET
Size
5.7 KB
Accession
0001209191-18-038717
Insider Transaction Report
Form 4
Avnur Zafrira
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-15+40,000→ 40,000 totalExercise: $23.27Exp: 2028-06-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]One half (1/2) of the shares underlying the option shall vest on June 15, 2019 (the "Cliff Vesting Date"), the remainder of the grant shall vest in equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001726049
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 9:31 PM ET
- Size
- 5.7 KB